AMAG Pharma (AMAG) Posts Q3 Loss of $1.88/Sh

November 1, 2018 7:10 AM EDT

AMAG Pharma (NASDAQ: AMAG) reported Q3 EPS of ($1.88), which may not compare to the analyst estimate of ($0.57). Revenue for the quarter came in at $122.2 million versus the consensus estimate of $120.1 million.

For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings